| Abstract: | 1. Detection of rheumatoid factors: isotypic variation and differential effect of penicillamine therapy. J. D. Wetherall, N. Buller, W. Strang and R. L. Dawkins, Department of Medical Technology, WAIT and Royal Perth Hospital, Perth, W.A. 2. Autoimmune responses to liver antigens in man regulated by suppressor T-lymphocytes . W. N. Bartholomaeus, W. D. Reed and R. A. Joske, Department of Medicine, University of Western Australia. Nedlands. W.A. 3. Circulating and tissue immune complexes in cutaneous vasculitis . B. S. Andrews, G. Cains, J. Mcintosh, V. Petts and R. Penny, Department of Immunology, St. Vincent's Hospital, Department of Medicine, University of N.S.W. 4. Detection of autoantibodies: a population study . K. J. O'Connor, R. L. Dawkins and B. Dawkins, Clinical Immunology Division, Royal Perth Hospital, Perth, W.A. 5. Specificity in lupus lymphocytotoxins . C. Witt, R. L. Dawkins, J. Richmond, K. Sagenschneider and P. J. Zilko, Department of Clinical Immunology; Royal Perth Hospital, Perth, W.A. 6. Reduced suppressor T-lymphocyte activity in myasthenia gravis. K. T. Holmes, P. J. Zilko and R. L. Dawkins, Department of Clinical Immunology, Queen Elizabeth IIMedical Centre, Perth, W.A. 7. Significance and characterization of a new class of antimuscle autoantibodies . B. L. McDonald, R. L. Dawkins, J. Robinson and P. H. Kay, Clinical Immunology Division, Royal Perth Hospital, Perth, W.A. 8. Adaptive immunity against old RBC? K. O. Cox and D. A. Cunliffe, School of Biological Sciences, The Flinders University of South Australia. 9. Blood pressure and metabolic effects of 9a-fluorohydrocortisone in sheep . J. P. Coghlan, D. A. Denton, J. S. K. Fan, J. G. McDougall, B. A. Scoggins, and J. A. Whitworth. Howard Florey Institute of Experimental Physiology and Medicine, Melbourne, Victoria 10. Exaggerated natriuresis in ACTH hypertension in sheep . J. A. Whitworth, J. P. Coghlan, D. A. Denton, J. S. K. Fan, J. G. McDougall and B. A. Scoggins, Howard Florey Institute of F. Experimental Phvsiology & Medicine. Melbourne. Victoria. 11. 5α-Dihydrocortisol, aldosterone and urinary electrolytes . W. R. Adam, J. W. Funder, J. Mercer and S. Ulick, Repatriation General Hospital, Heidelberg 3077; INSERM U7, Hõpital Necker, 75015 Paris; Medical Research Centre, Prince Henry's Hospital 3004; and Bronx V.A., New York 10468. 12. The effect of dopamine on pig kidney medullary Na+K+ ATPase as measured by 3H] ouabain binding . W. R. Adam. Repatriation General Hospital. Heidelberg. 3077. 13. Angiotensin III specific receptors in the rat adrenal gland. P. G. Matthews, M.-G. Pernollet, M.-A. Devynck and P. Meyer, INSERM U7, HõpitalNecker, 75015, Paris, France. 14. Localization of immunoreactive angiotensins in rat brains . J. S. Hutchinson and J. Csicsmann, Baker Medical Research Institute, Melbourne. 15. Isolation of a new peptide in the central nervous system . Fiona Furby, Claire Baxter, G.G. Duggin, J.S. Horvath and D.J. Tiller, Renal Unit, Royal Prince Alfred Hospital, New South Wales. 16. Plasma catecholamines and the blood pressure response to saralasin infusion. B . McGrath, C. Benedict, J. Ledingham, C. Baxter, J. Horvath and D. Tiller, Radcliffe Infirmary Oxford U.K. and Royal Prince Alfred Hospital, Sydney, Australia. 17. Bile acid structure and biliary lipid secretion in the cat. R. B . Sewell, N. E. Hoffman and R. A. Smallwood, Gastroenterology Department, Austin Hospital, Melbourne. 18. The effect of bilateral ureteric ligation on bile acid sulphation in normal and biliary obstructed rats . Malcolm Mackinnon and Christine McGuffie, Department of Medicine, Flinders Medical Centre, Bedford Park, South Australia. 19. Cholic acid (CA) binding proteins in rat liver cytoplasm. M. J. McClelland, N. E. Hoffman , R. A. Smallwood and N. J. Hoogenraad, Department of Medicine, Austin Hospital and Department of Biochemistry, LaTrobe University. 20. Study of sulfobromophthalein metabolism-depression by diethyl maleate. G. Whelan , Dept. of Medicine, University of Melbourne, St. Vincent's Hospital, Melbourne. 21. Intestinal sugar transport after bile fistula . Valerie Burke and Michael Gracey, Princess Margaret Children's Medical Research Foundation, Perth, W.A. 22. Nature of hormone which regulates intrinsic factor vitamin B12 receptor activity in mouse small intestine . J. A. Robertson and N. D. Gallagher A. W. Morrow, Department of Gastroenterology, Royal Prince Alfred Hospital, Sydney N.S. W. 23. Alterations in hepatic cobalamin distribution in liver disease. J. A . Gall and W. G. E. Cooksley, Department of Biochemistry, University of Queensland, Royal Brisbane Hospital, Brisbane. 24. Effect of liver damage on hepatic vitamin B12 metabolism J. A. Owens and W. G. E. Cooksley, Department of Biochemistry, University of Queensland, Royal Brisbane Hospital, Brisbane. 23. The effects of smoking on drug metabolism . G. C. Farrell, W. G. E. Cooksley, G. A. Cash and L. W. Powell, University Departments of Medicine and Biochemistry, Royal Brisbane Hospital, Brisbane. 26. Changes in antipyrine metabolism after drug ingestion by cigarette smokers . G. A. Cash, G. C. Farrell, W. G. E. Cooksley and L. W. Powell, University Departments of Biochemistry and Medicine, Royal Brisbane Hospital, Brisbane. 27. Effect of short term fasting on drug metabolism . C. Holt, G. C. Farrell, W. G. E. Cooksley and L. W. Powell, University Departments of Biochemistry and Medicine, Royal Brisbane Hospital, Brisbane. 28. Acetylation of hepatic proteins by aspirin: a possible role in aspirin hepatotoxicity . Robyn J. Caterson.G. G. Duggin, J.Mohandas, J. Horvath and D. Tiller, Royal Prince Alfred Hospital, Sydney. 29. Renal oxidative metabolism of drugs in CS7B1/6J mouse J . Mohandas, I. C. Calder* and G. G. Duggin, Renal Unit, Royal Prince Alfred Hospital, Camperdown, N.S.W. and * Department of Organic Chemistry, University of Melbourne, Victoria. 30. Pharmacokinetics of prednisone and prednisolone . J. A. Caffin, J. W. Halliday, A. R. Tanner, F. Bochner and L. W. Powell, Department of Medicine, University of Queensland, Royal Brisbane Hospital, Brisbane. 31. Procainamide in intermittent atrioventricular block . A. M. Tonkin and W. F. Heddle, Department of Medicine, Flinders University, Adelaide. 32. The acute effects of labetalol hydrochloride on the physiological response to exercise . S. D. Anderson, G. Hamor, S. Gowans & G. G. Duggin, Departments of Thoracic Medicine and Nephrology, Royal Prince Alfred Hospital, Camperdown, N.S. W. 33. Platelet function in a child with severe combined immune deficiency and adenosine deaminase deficiency . C. H. Lee, S. Evans, M. C. Rosenberg, J. B. Ziegler and M. B. van der Weyden, Prince Henry and Prince of Wales Hospitals, Sydney and Alfred Hospital, Melbourne. 34. Coagulant activities of human plasma lipoproteins. P . Vijayagopal and N. G. Ardlie, Department of Clinical Science, Australian National University Canberra, A.C.T. 35. Effect of quinine on coagulation activity of platelets . P. K. Hozzeinzaden, S. L. Pfuller and B. G. Firkin, Department of Medicine, Monash University Medical School, Melbourne. 36. Identification of a bypass mechanism of the classical intrinsic clotting pathway by platelets . B. G. Firkin, P. Booth, L. Stott and M. A. Howard, Dept. Medicine, Monash University Med. School, Alfred Hospital. 37. Plasma proteins required for the interaction between platelets and particulate matter. Sharron L. Pfueller, Department ofMedicine, Monash University, Alfred Hospital, Melbourne. 38. Effect of thrombin on incorporation of 3H]glycerol into phospholipids of human platelets. J. V. Lloyd, Department of Clinical Science, John Curtin School of Medical Research Australian National University, Canberra, A.C.T. 39. The diagnostic problem of acquired von Willebrand's disease. S. E. Watts, M. J. Hooper, E. Byrne and J. V. Lloyd, Department of Haematology, Institute of Medical and Veterinary Science, and Department of Endocrinology, Royal Adelaide Hospital, South Australia. 40. Studies on the structure and subunit composition of human antihemophilic factor. J.J. Gorman and H. Ekert, Department of Clinical Haematology and Oncology', Royal Children's Hospital, Melbourne, Australia. 41. Isolation and characterization of blocking factors in the sera of melanoma patients. Elaine Murray and P. Hersey, Medical Research Department, Sydney Hospital. 42. Characterization of a heterophile antibody system by antibody dependent cell-mediated cytotoxicity. D. J. Feeney, G. C. Saueracker, R. L. Dawkins and B. L. McDonald, Clinical Immunology Division, Royal Perth Hospital, Perth, Western Australia. 43. Loss of antibody-forming potential in old mice is associated with the appearance of nonspecific suppressor T-cells. R.E. Callard, Immunology Unit, Dept. of Bacteriology, University of Sydney. 44. Regulation of antibody production by suppressor T-cells. R. Loblay, H. Briscoe and I. Wilcox. Immunology Unit, Dept. of Bacteriology, University of Sydney, Sydney. 45. Immunologic memory and lymphocyte regulation in the human mucosa. R. Clancy, A. Pucci, P. Pye and T. Jelibovsky, Departments of Immunology, Thoracic Medicine and Pathology, Royal Prince Alfred Hospital, Sydney. 46. Retroviruses in human cancer. F. C. Wilson, H. J. Thome and D. G. Jose, Clinical Immunology and Immunogenetics Unit, Cancer Institute, Melbourne. 47. A murine model for treatment of micrometastases. P. A. Gatenby, Immunology Unit, Dept. of Bacteriology, University of Sydney. 48. T-cell dependence of the sneak through phenomenon. P. A. Gatenby and A. Basten, Immunology Unit, Dept. of Bacteriology, University of Sydney. 49. Screening of cord blood low density lipoprotein cholesterol (LDL-C) in the diagnosis of familial hypercholesterolemia (FH). T. J. Boulton, I. H. Craig, G. Hill and L. Coote, University of Adelaide and Adelaide Children's Hospital. 50. Cholesterol homeostasis in infants. A. B. Poyser, P. J. Nestel and J. Boulton*, Baker Medical Research Institute, Melbourne, and *Department of Paediatrics, Adelaide Children's Hospital. 51 . Very low density lipoprotein turnover and triglyceride metabolism in man. M. F. Reardon, P. J. Nestel and N. H. Fidge, Baker Medical Research Institute, Melbourne. 52. Studies of HDL esterified cholesterol: a new technique. J. I. Lally and P. J. Barter, Flinders Medical Centre, Bedford Park, South Australia. 53. Diet-induced alterations of serum lipids and lipoproteins. I. Linton, A. Warrell, B. Cham and P. Owens, Department of Medicine, University of Queensland, Royal Brisbane Hospital. 54. Biochemical and ultrastructural studies of the synthesis of elastin, proteoglycans and collagen by neonatal rat aortic smooth muscle cells in tissue culture. B. W. Oakes, A. C. Batty, and C. J. Handley, Monash University, Australia. 55. Serum ferritin estimation in screening for familial haemochromatosis. R. N. Murray, K. L. Gera, K. B. Shilkin and W. D. Reed, Gastroenterology/Liver Unit and University Department of Medicine, Queen Elizabeth II Medical Centre, Nedlands, W.A. 56. Sandwich immunoradiometric assay for serum ferritin using commercial antiserum. K. L. Gera and W. D. Redd, Gastroenterology/Liver Unit and University Department of Medicine, Queen Elizabeth II Medical Centre, Nedlands, W.A. 57. The kinetics of tissue and serum ferritins. U. Mack, L. W. Powell and J. W. Halliday, Department of Medicine, University of Queensland, Royal Brisbane Hospital, Brisbane. 58. Morphometric assessment of bronchiolar calibre in man. N. Berend, G. E. Marlin and A. J. Woolcock, Respiratory Unit, R.G.H. Concord and the University of Sydney, N.S.W., Australia. 59. Protective effect of the aerosol beta adrenergic drug (BEROTEC) on bronchial response to methacholine in asthma. Lucy J. Vautin and Ann J. Woolcock, Department of Medicine, The University of Sydney, Sydney. 60. An in vitro model of bronchial hyper-reactivity. Brian Creese and M. A. Denborough, Department of Qinical Science, John Curtin School of Medical Research, The Australian National University, Canberra, A.C.T. 61. Statistical analysis of data expressed as a percentage change. M. W. Jones and Ann. J. Woolcock, Department of Medicine, Sydney University. 62. Microfilament distribution in cell death by apoptosis. W. M. Clouston and J. F. R. Kerr, Department of Pathology, University of Queensland. 63. Induction of cytological variations in human synovial cell lines. B. J. Clarris, J. R. E. Fraser and E. Baxter, University of Melbourne, Department of Medicine, Royal Melbourne Hospital, Melbourne. 64. Infertility after azathioprine therapy. H. P. Roeser and A. Nikles, Department of Medicine, University of Queensland, Royal Brisbane Hospital, Brisbane. 65. Enhancement of leucocidal activity by brief exposure to antibiotic. H. Pruul and P. J. McDonald, Clinical Microbiology, Flinders Medical Centre, Adelaide. 66. Inhibitors of human spleen dihydro-orotate dehydrogenase. Annette Gero and W. J. O'Sullivan, School of Biochemistry, University of New South Wales, Sydney, N.S. W. 67. Ia antigens in immune responses. I. F. C. McKenzie, M. Sandrin and C. R. Parish, Department of Medicine, Austin Hospital, Heidelberg, Victoria and Department of Microbiology, Australian National University, Canberra. 68. HLA and disease: review of genetic and statistical considerations. J. D. Mathews, University of Melbourne, Department of Medicine, Royal Melbourne Hospital, Victoria. 69. HLA-BW15 and HLA-BW17: linkage disequilibria with other HLA antigens. J. B. Houliston, J. D. Wetherall, B. Hawkins and R. L. Dawkins, Department of Clinical Immunology, Royal Perth Hospital and QE11 Medical Centre, Perth, W.A. 70. Myasthenia gravis and HLA: relationship to autoimmunity, immunodeficiency and thymic disease in patients and their relatives. F. T. Christiansen, R. L. Dawkins and B. Houliston, Clinical Immunology Division, Royal Perth Hospital, Perth, Western Australia. 71. HLA antigens and disease in the busselton population. R. R. Hawkins and P. L. Dawkins, Department of Clinical Immunology, Queen Elizabeth II Medical Centre, Perth. W.A. 73. Ethanol metabolism. M. N. Berry, Flinders Medical Centre, Adelaide, South Australia. 74. Vitamin deficiency in alcoholism, with particular reference to thiamine deficiency. B. Wood and K. J. Breen, Dept. of Medicine, University of Melbourne, St Vincent's Hospital, Melbourne, Victoria. 75. Pathogenetic mechanisms in alcoholic liver disease. R. A. Small wood, Department of Medicine. Austin Hosvital. Heidelbere. 76. Pituitary-gonadal axis in alcoholism and liver disease. H. W. G. Baker, Howard Florey Institute of Experimental Physiology & Medicine, Melbourne, Victoria. 77. Social, psychological and economic aspects of alcoholism: recent advances. Ms. Margaret Hamilton, Dept. of Social Studies, University of Melbourne, Melbourne. 78. Myocardial cell suspensions for biochemical study of ischaemia. M. G. Clark, C. S. E. Wurm, G. S. Patten and M. N. Berry, Clinical Biochemistry Unit, Flinders University Medical School, S.A. 79. Myocardial substrate requirements. M. L. Wahlqvist, Department of Medicine, Monash University, Prince Henry's Hospital, Melbourne, Australia. 80. Physiological determinants of cardiac oxygen consumption. C. L. Gibbs, Department of Physiology, Monash University, Clayton, Victoria. 81. Protein turnover in the normal and hypertrophying myocardium. M. P. Sparrow, A. W. Everett, G. J. Laurent, Caroline M. Bonnin and R. R. Taylor, Pharmacology Department, University of Western Australia, Nedlands, W.A. 82. Limiting factors in myocardial ischaemia. J. Eason, R. Bonyhady and J. F. Williams, Biochemistry Department, Faculty of Science, Australian National University, Canberra. 83. Cardiac metabolism of short and long chain fatty acids and of carbohydrate in conscious dogs. S. P. Lim, M. L. Wahlqvist, E. Anne Shanahan, I. G. Jarrett, O. H. Filsell and E. G. Wilmshurst, Departments of Medicine and Surgery, Monash University, Melbourne; Division of Human Nutrition, CSIRO, Adelaide and Department of Endocrinology, Royal North Shore Hospital, Sydney. 84. Turnover rates of muscle proteins in cardiac, skeletal and smooth muscle: turnover rate related to muscle function. Caroline M. Bonnin, G. J. Laurent, A. W. Everett, and M. P. Sparrow, Pharmacology Dept., University of Western Australia, Nedlands, W.A. 85. Protein synthesis during the rapid phase of cardiac hypertrophy in the dog. A. W. Everett, R. R. Taylor and M. P. Sparrow, Depts. of Pharmacology and Medicine, University of Western Australia, Nedlands, W.A. 86. Synthesis of muscle proteins and collagen during hypertrophy of skeletal muscle. G. J. Laurent, M. P. Sparrow and D. J. Millward, Department of Pharmacology, University of Western Australia, Nedlands, W.A. 87. Water and electrolyte exchange in arteries: effect of 1-epinephrine and passive stretch. J. K. Healy and J. Oweczkin, LIONS Research Laboratory, Princess Alexandra Hospital, Brisbane. 88. Evolution of trace proteinuria in diabetes mellitus. G. Jerums, E. Seeman, R. M. L. Murray and P. Smith, Endocrine Unit and Department of Medicine, Austin Hospital, Heidelberg. 89. Pharmacokinetics of Mesamino-8-D-arginine-vasopressin (DDAVP) in central diabetes insipidus. P. T. Pullan and C. I. Johnston, Monash University Department of Medicine, Prince Henry's Hospital, Melbourne. 90. Inhibition of adrenergic neurotransmission by histamine and 5-hydroxytryptamine. Michael A. McGrath and John T. Shepherd, Mayo Clinic & Mayo Foundation, Rochester, Minnesota, U.S.A. 91. The effect of a transaminase inhibitor on oxalate synthesis in vitro. A. M. Rofe and J. B. Edwards, Division of Clinical Chemistry, Institute of Medical & Veterinary Science, Adelaide. 92. Adenosine-3′,5′-monophosphate and insulin secretion. R. G. Larkins and Lillian Simeonova, University of Melbourne Dept of Medicine, Royal Melbourne Hospital, Melbourne. 93. Aortic glycosaminoglycans in non-diabetes and diabetic rabbits. P. Muthiah, P. S. R. Murthy and S. K. Mukherjee, Department of Pathology, The University of Adelaide, S.A. and Central Drug Research Institute, Lucknow, India. 94. Hereditary stomatocytosis: association of low diphosphoglycerate with increased cation pumping. J. S. Wiley, R. A. Cooper and T. Asakura, Department of Medicine, Austin Hospital, Melbourne and University of Pennsylvania Medical School, U.S.A. 95. Cytokinetic studies in children with untreated acute lymphocytic leukaemia (ALL): relationship to cell markers. Barbara Dobrostanski and Henry Ekert, Department of Clinical Haematology and Oncology, Royal Children's Hospital, Melbourne. 96. The establishment of an adenosine deaminase deficient lymphoblastoid cell line. M. B. van der Weyden, I. Jack, C. H. Lee and J. B. Ziegler, Monash University Medical School Alfred Hospital, Royal Children's Hospital, Melbourne, and Prince Henry & Prince of Wales Hospitals, Sydney. 97. Activation of the granulocyte cell surface NADH oxidase. Catharine Dewar, Department of Medicine, University of Tasmania, Australia. 98. Lecithin induced eosinophilia. G. T. Archer, J. Jindra, June Robson and Judith Smith, New South Wales Red Cross Blood Transfusion Service, Sydney, Australia. 99. Effect of colony stimulating factors) (CSF) on granulocyte-macrophage progenitor recovery after treatment of mice with 5-FU. G. S. Hodgson and T. R. Bradley, Biological Research Unit, Cancer Institute, Melbourne. 100. Epidemiology and experimental research-a symbiotic relationship. B. K. Armstrong, Department of Medicine, University of Western Australia, Perth, W.A. 101. Immunovirology of malignant disease. D. G. Jose, Clinical Immunology and Immunogenetics Unit, Cancer Institute, Melbourne. 102. Chemical carcinogenesis. B. W. Stewart, School of Pathology, University of New South Wales, Kensington. 103. Drug treatment of cancer. M. H. N. Tattersall, Ludwig Institute for Cancer Research, The University of Sydney, Sydney, N.S. W. 104. The psychobiology of weight loss. R. S. Kalucy, Department of Psychiatry, Flinders Medical Centre, Bedford Park, South Australia. 105. Enkephalin. Geoffrey W. Tregear , Howard Florey Institute, University of Melbourne, Parkville. 106. HLA and disease. W. F. Bodmer , Genetics Laboratory, University of Oxford, Oxford, England. |
